Scalper1 News
Auxilium Pharmaceuticals’ (AUXL) board said Monday that a $2.2 billion takeover offer from Endo International “significantly undervalues” the company. But the specialty-drug maker stopped short of an outright rejection of the unsolicited takeover bid from Endo (ENDP) and left open a chance of further discussions on a potential deal. Auxilium stock was nearly flat on the stock market today on the news, while Endo’s was down over 2.5%. Chesterbrook, Scalper1 News
Scalper1 News